Newsroom

As news emerged this week that an experimental vaccine against covid-19 has proved effective in late-stage clinical trials, hopes that the pandemic’s days may be numbered are running high. Read more at Economist.

While immunotherapies work well for some cancers, others are immune-resistant and condemn patients to the severe side effects of long-term chemo treatment. A new cancer vaccine successfully treated immune-resistant breast cancer in mice, 100% of which survived a second injection of cancer cells, indicating long-term immunity with no side effects.

A new study lays out a large medical analytics framework that can be used in neuroscience and neurology to study brain connectivity in living organisms.

Scientists have developed a method to bioprint a type of cartilage that could someday help restore knee function damaged by arthritis or injury.

New SARS-CoV-2 rapid tests, which can deliver results in a matter of minutes in the field rather than taking days in clinical diagnostic labs, are starting to become widely available. Read more at Nature biotechnology.

The COVID-19 Test Us program was conceived soon after the RADx launch in April to facilitate clinical studies for testing technologies in the real-word setting.

Researchers reported developing a cardiac patch made from fully rubbery electronics that can be placed directly on the heart to collect electrophysiological activity, temperature, heartbeat and other indicators, all at the same time.

The coronavirus outbreaks at the White House, first among President Trump and his inner circle and now circulating among Vice President Mike Pence’s staff, illustrate some of the limits of Covid-19 diagnostic tests. Read more at Forbes.

A scientist and entrepreneur is working to use simple LED light to help determine if certain chemotherapy options will work for specific patients.